Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9847096 | 0.87 | HTT (0.54) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL31453606 | 0.81 | L3MBTL1 (0.49) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL31484147 | 0.81 | MAPT (0.64) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL25036286 | 0.80 | NOS3 (0.39) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL1576738 | 0.78 | CYP1A2 (0.55) | CYP1A2L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL10394977 | 0.74 | CYP1A2 (0.52) | CYP1A2L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL30397292 | 0.74 | KDM4E (0.46) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL25205112 | 0.74 | KDM4E (0.46) | CYP1A2L3MBTL1GAAKMT2AMEN1 | |
| SCHEMBL12411173 | 0.73 | CYP1A2 (0.50) | CYP1A2GAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL8347801 | 0.73 | CYP1A2 (0.50) | CYP1A2L3MBTL1GAALMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2250998-B1 | SKIN WHITENING AGENT AND EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO CO LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-8563552-B2 | Whitening agent and skin external preparation | SHISEIDO COMPANY LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20110003817-A1 | Whitening Agent And Skin External Preparation | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2250998-A1 | SKIN WHITENING AGENT AND EXTERNAL PREPARATION FOR THE SKIN | Shiseido Company, Ltd. (JP) | 2010-11-17 | — | — | EP | disclosed |
| CN-1114603-C | Hydrazono-1,3-dithiocyclopentane derivative and synthesizing method | UNIV SICHUAN (CN) | 2003-07-16 | — | — | CN | disclosed |
| CN-1217331-A | Hydrazono-1,3-dithiocyclopentane derivative and synthesizing method | HUAXI MEDICAL UNIV (CN) | 1999-05-26 | — | — | CN | disclosed |
| WO-1994022853-A1 | HERBICIDAL 1-HETEROARYL PYRAZOLIDIN-3,5-DIONES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1994-10-13 | — | — | WO | disclosed |
| US-5091529-A | HERBICIDAL SUBSTITUTED SULPHONYLAMINOAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-25 | — | — | US | disclosed |
| EP-0457140-A2 | Phenoxyphenyl sulfonyl compounds | BAYER AG (DE) | 1991-11-21 | — | — | EP | disclosed |
| US-5021082-A | Pre=and postemergent | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0419831-A2 | Substituted sulfonylaminoazoles | BAYER AG (DE) | 1991-04-03 | — | — | EP | disclosed |
| US-4941912-A | Herbicidal substituted sulphonylaminoazoles | BAYER AKTIENGESELLSCHAFT (DE) | 1990-07-17 | — | — | US | disclosed |
| EP-0330959-A2 | Substituted sulphonyl amino azoles | BAYER AG (DE) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003817-A1 | Whitening Agent And Skin External Preparation | TYR, MC1R, RTN3 | CYP1A2 420/4885L3MBTL1 4788/4885GAA 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.